MedPath

Artificial intelligence-derived gut microbiome as a predictive biomarker for therapeutic response to immunotherapy in lung cancer

Not Applicable
Not yet recruiting
Conditions
ung cancer
Registration Number
JPRN-UMIN000051705
Lead Sponsor
ational Hospital Organization
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
326
Inclusion Criteria

Not provided

Exclusion Criteria

i.Diseases eligible for definitive chemoradiotherapy. ii.Patients deemed inappropriate for the study by the investigator.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.